New Products & Services

Once-daily agent for OAB is approved by FDAEast Hanover, NJ-Novartis Pharmaceuticals Corp. has announced that the FDA has approved darifenacin (Enablex) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Darifenacin is a once-daily medication.

It is a muscarinic receptor antagonist that helps reduce incontinence episodes, increases the amount of urine the bladder can hold, reduces the frequency of urination episodes, and decreases the pressure or urgency associated with the urge to urinate.

FDA approval was based on data from four studies and safety data from studies in which more than 7,000 patients with a mean age of 58 years were treated with various doses. It was shown to reduce weekly incontinence episodes by up to 83% and results were seen within 2 weeks of beginning treatment.

For more information, visit www.enablex.com.

Generic version of agent for dysuria now availableMinneapolis-A generic version of flavoxate hydrochloride, 100 mg, is now available in bottles of 100 tablets.

Flavoxate is indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency, and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis. It is not indicated for definitive treatment but is compatible with drugs used for the treatment of urinary tract infections, according to the manufacturer, Paddock Laboratories, Inc.

For more information, visit www.paddocklabs.com.

Tiny device lets patients carry medical recordsSouth Euclid, OH-Dx-PRN, Inc. has applied the technology for jump drives-small, electronic information storages devices-and applied them to patient records. The JumpStart drive can hold a patient’s medical records, but is small enough that it can be attached to a key chain or worn in the same manner as medical alert jewelry.

JumpStart plugs into the USB port of a computer and allows health care providers to view and print the patient’s medical records. Dx-PRN will update the medical records three times within 2 years of purchase, and a subscription is available after that period.

For more information, visit www.Dx-PRN.com.

Multiple input options offered for EMR systemsNew York-OmniMD now offers multiple data input options for it electronic medical record systems. This allows physicians to enter data manually with a keyboard, select from point-and-click options, or send dictation through OmniMD’s transcription service.

For more information, visit www.omnimd.com.

Domain .md now available to physiciansJersey City, NJ-In addition to more familiar internet domain addresses-.com, .net, .edu - the domain .md is now available to physicians and others in the health care industry through MaxMD. The domain is one of the hundreds created for countries, in this case Moldova, but is available for purchase to through a private company.

MaxMD offers domain registration, e-mail, and instant messaging services tailored to the needs of health care professionals. The services meet federal requirements for protecting patients’ rights.

For more information, visit www.max.md.